TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pharma Majors Collaborate for Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for COVID-1929-06-2021
29-06-2021
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement regarding intimation of the 48th AGM of the Company through VC / OAVM facility29-06-2021
Torrent Pharmaceuticals Ltd - 500420 - Closure of Trading Window
Pursuant to Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons of the Company (''Code'') and applicable SEBI Regulations, we would like to inform you that trading window for dealing in securities of the Company by Designated Persons stands closed from 1st July, 2021 and will be re-opened 48 hours after the submission of the Financial Results for the Quarter ended 30th June, 2021 to the Stock Exchanges.29-06-2021
TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate21-06-2021
Torrent Pharmaceuticals Ltd - 500420 - Redemption Of Commercial Papers
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Commercial Paper of ? 100 crores (Rupees One Hundred Crores) issued on 15th December, 2020 under ISIN: INE685A14096 has been fully redeemed and repaid by the Company on maturity date i.e. 11th June, 2021.11-06-2021
Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investor Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201509-06-2021
TORRENT PHARMACEUTICALS LTD. - 500420 - Compliance As Per Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed the Related Party Transactions on a consolidated basis for the half year ended on 31-Mar-21. Kindly take note of the above.07-06-2021
Hope to launch diabetic NCE by next financial year: Torrent Pharma's Mehta
We would also look into distribution opportunities to bring some of these products into the market, said Mehta05-06-2021
Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement in respect of the transfer of shares to IEPF04-06-2021
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investor Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201503-06-2021